Shimla, Oct. 7 -- The Himachal Pradesh government has banned Coldrif cough syrup following the death of nine children from fever in Chhindwara, Madhya Pradesh. The moves comes after the office of the director of drugs control, Tamil Nadu, declared ColdRif Syrup (Paracetamol, Phenylephrine Hydrochloride, and Chlorpheniramine Syrup) batch number SR-13, manufactured by Sresan Pharmaceutical Manufacturer, Kancheepuram district, Tamil Nadu, as not of standard quality after it was found adulterated. "We have completely banned the drug. The retailers, distributors, hospitals, and medical practitioners have been instructed not to purchase or use the drug under any circumstances, and any existing stock must be reported to the drugs control administration immediately," said state drug controller Manish Kapoor while talking to HT. However, the Nexa DS cough syrup manufactured in Himachal Pradesh's Baddi area has cleared testing, officials said on Monday The MP government had written to Himachal as well as the state's drug controller, seeking an investigation into two syrups - Coldrif and Nexa DS. Coldrif is not produced in Himachal, however, Nexa DS is manufactured by Aquanova Pharma. The Himachal drug department had suspended the production of Nexa DS as a precautionary measure while the laboratory results were awaited. "As a precautionary measure the production of Nexa DS was stopped. We have now received the communication saying that the samples of Nexa DS cough syrup, manufactured in Baddi, Himachal, has been cleared in the test." Samples of the medicine were sent for testing after the death of 14 children from suspected renal failure linked to the consumption of a "toxic" cough syrup in Madhya Pradesh. Kapoor, said, "After receiving the communication from MP, the department immediately began an inquiry." "We have received communication from MP where by the sample of the Nexa DS have been declared of standard quality," he said. htc...